Testosteronan, an unusual glycosaminoglycan (GAG) first isolated from the microbe Comamonas testosteroni, was enzymatically synthesized in vitro by transferring uridine diphosphate sugars on b-p-nitrophenyl glucuronide acceptor.
INTRODUCTION
G lycosaminoglycans (GAGs) are linear polysaccharides consisting of a repeating hexosamine-containing disaccharide unit. These polymers are usually found in the extracellular matrix of animal cells and have a wide variety of biological functions. In certain pathogenic bacteria, GAGs are synthesized as an extracellular coating or polysaccharide capsule, which acts as a molecular camouflage during the entry into a vertebrate host. 1 This polysaccharide capsule is biosynthesized either by complexes of monofunctional glycosyltransferases or by bifunctional GAG synthases that assemble the GAG from uridine diphosphate (UDP)-sugars. 2 For example, the Pasteurella multocida GAG synthases PmHS1 and PmHS2 employ UDP-N-acetyl glucosamine (GlcNAc) and UDP-glucuronic acid (GlcA) to construct heparosan, which has the repeating backbone [-4-D-GlcA-b1,4-D-GlcNAc-a1-] n , and is a biosynthetic precursor to heparan sulfate (HS). 3 Heparin and HS are sulfated GAGs that are known to regulate important biological processes. 4 In their biosynthesis, their basic backbone heparosan undergoes O-and N-sulfonation and epimerization by modification enzymes: O-sulfotransferases (OSTs), N-deacetylase sulfotransferase (NDST), and C5-epimerase (C5-epi). These enzymes have been cloned and expressed and used to modify heparosan-like oligosaccharides in vitro to prepare heparin oligosaccharides with anticoagulant activity. 5, 6 Recently, we reported the cloning of a novel GAG synthase, CtTS from Comamonas testosteroni, 7 a Gram-negative aerobic bacteria and human pathogen. 8 The GAG produced by C. testosteroni has an unusual backbone structure [-4-D-GlcA-a1,4-D-GlcNAc-a1-] n , which contains the same sugar composition as heparosan but a different glycosidic linkage stereochemistry at the GlcA residue. In heparosan, the linkage between GlcA and GlcNAc is in b-form, while in the GAG from C. testosterone, the linkage is in a-form. As a result of its distinctive glycosidic linkage, this novel GAG, testosteronan, is insensitive to digestion by GAG lyases. 7 This suggested that sulfated testosteronan could resemble heparin and HS to bind to a variety of proteins, but afford catabolically resistant analogs having therapeutic potential.
In this manuscript, we describe the in vitro enzymatic synthesis of testosteronan on a b-p-nitrophenyl glucuronide acceptor and the chemical modification of the resulting testosteronan polysaccharide to obtain N-sulfotestosteronan. N-Sulfotestosteronan is structurally similar to N-sulfoheparosan, a natural substrate for HS biosynthetic enzymes. 9 Next, the further modification of N-sulfotestosteronan by OSTs involved in HS biosynthesis was examined. A non-enzymatic method was required to prepare oligosaccharide fragments to monitor the enzymatic modification of N-sulfotestosteronan polysaccharide. The O-sulfonation of N-sulfotestosteronan oligosaccharides was established using liquid chromatography (LC)-mass spectrometry (MS). Two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy was used to establish the position of the O-sulfo group and surface plasmon resonance (SPR) was used to profile the structure and protein-binding activity of this new polysaccharide.
RESULTS

In Vitro Synthesis of Testosteronan
Testosteronan was synthesized in vitro using p-nitrophenyl b-glucuronide as the acceptor, UDP-sugars as the donors, and recombinant testosteronan synthase, CtTS, as the catalyst ( Figure 1 ). The acceptor was not efficiently incorporated (thus was present at high concentration in the reaction), but its presence narrowed the size distribution of testosteronan significantly over "no acceptor" reactions. Two sizes of the polysaccharide were prepared from the reaction mixture by a strong anion exchange chromatographic separation. The size of the resulting testosteronan polysaccharides was determined using polyacrylamide gel electrophoresis (PAGE) ( Figure 2 ) and Multi-Angle Laser Light Scattering (MALLS). By MALLS, the average molecular weight/polydispersity values for the 0.8M and the 1.0M ammonium formate-eluted fractions were 38.3 kDa/1.136 and 78.3 kDa/1.057, respectively.
Chemical Synthesis of N-Sulfotestosteronan
The chemical conversion of testosteronan to N-sulfotestosteronan was based on our previously described conversion of heparosan to N-sulfoheparosan ( Figure 3) . 9, 10 The N-acetyl group of testosteronan was removed by chemical de-N-acetylation by treatment with 2M NaOH at 60 C overnight followed by chemical N-sulfonation by the addition of NMe 3 ÁSO 3 (Figure 3 ). After purification of the polysaccharide, the structure of N-sulfotestosteronan was confirmed using one-dimensional 1 H-NMR ( Figure 4 ). The successful removal of the N-acetyl group from testosteronan was established by the nearly complete disappearance of the signal at 2.0 ppm, corresponding to the methyl group of the N-acetyl group in GlcNAc. Integration of the residual N-acetyl peak demonstrates a conversion of more than 95% on the GlcNAc residues to GlcNS residues. The conversion of GlcNAc to GlcNS could also be confirmed by the downfield chemical shift of the anomeric proton in GlcNAc (5.3 ppm) with the formation of GlcNS at 5.6 ppm. In the heteronuclear multiple-quantum correlation (HMQC) spectrum, the 13 C signal for C2 of GlcNS residue was observed at 58.0 ppm as compared to 51.9 ppm in GlcNAc residue (Figure 5A ), corresponding to a significant downfield shift. These chemical shift changes are comparable to the chemical shift changes observed in the de-N-acetylation and N-sulfonation of heparosan in the preparation of N-sulfoheparosan. 9 Based on these spectral data, it was concluded that testosteronan had been successfully converted to N-sulfotestosteronan,
Survey of the Reactivity of N-Sulfotestosteronan with O-Sulfotransferases
Next, to discover whether N-sulfotestosteronan was a substrate for HS biosynthetic enzymes, we treated N-sulfotestosteronan with various sulfotransferases and (Table I) . Next, 3OST-1 was examined and showed a low level of radiolabel incorporation (Table II) , suggesting that 3OST-1 cannot modify N-sulfotesteronan. Finally, 6OST-1 and 6OST-3 were compared and both isoforms showed similar levels of radiolabel incorporation (Table III) . The [ 35 S] PAPS used varied in its specific activity over the timeframe during which the data presented in Table I were collected. To normalize the data in these three sets of experiments, a negative control (containing no added enzyme) was set to 0% incorporation and a positive control (using N-sulfoheparosan treated with both 6OST-1 and 6OST-3) was set to 100% incorporation. While the data obtained, in each set of experiments, on the incorporation of 35 S into N-sulfotestosteronan treated with both 6OST-1 and 6OST-3 varied somewhat (114-169% of the positive control), the data demonstrated that the combination of 6OST-1 and 6OST-3 generally gave the highest level of incorporation. On the basis of these studies we decided to examine the incorporation of O-sulfo groups into Nsulfotestosteronan using a mixture of 6OST-1 and 6OST-3. Based on the [ 35 S] sulfo group incorporation studies we anticipated a 20% incorporation of 6-O sulfo group.
Synthesis of 34 S-Labeled 6-O-Sulfo-Nsulfotestosteronan
Using a mixture of 6OST-1 and 6OST-3, N-sulfotestosteronan was sulfonated using 34 S-labeled PAPS to incorporate a nonradioactive isotope, which would assist in measuring incorporation of O-sulfo groups by MS analysis. N-sulfotestosteronan was incubated for overnight at 37 C with 6OST-1, 6OST-3, and 34 S-labeled PAPS and the product was purified by a diethylaminoethyl (DEAE) column for the structural analysis. It was essential to use 34 S-labeled PAPS ( Figure 5A ) as exhaustive chemical N-sulfonation can introduce very small amounts of O-sulfo groups through a mechanism that is still unclear (possibly direct O-sulfonation followed by N-to O-sulfo group 
Oxidative Cleavage of 6-O-Sulfo-Nsulfotestosteronan and LC-MS Analysis
To utilize LC-MS to analyze the incorporation of O-sulfo groups into N-sulfotestosteronan, the polysaccharide must first be broken down to oligosaccharide fragments. Hydroxyl free radicalmediated, controlled depolymerization of 6-O-sulfo-N-sulfotestosteronan using copper (II) and hydrogen peroxide 11 at pH 7.0 afforded oligosaccharides that were then analyzed by hydrophilic liquid interaction chromatography (HILIC) LC-Fourier transform mass spectrometer (FTMS). The total ion chromatogram showed oligosaccharides ranging from trisaccharide, degree of polymerization (dp)3, to dp>22 ( Figure 5B ).
34
S-labeled oligomers can be identified from dp3 to dp12, and both even and odd chains of oligomers were detected in the depolymerized samples. Every odd number chain has two corresponding peaks, the first peak corresponding to a chain with an additional GlcNS residue, and the second (labeled with an asterisk *) corresponding to an additional GlcA residue. From the mass spectra of the oligosaccharides, 34 S-labeled-sulfated oligosaccharides were detected and confirmed by FTMS elemental component analysis (dp4 and dp8 are shown in Figure 5C as examples). Based on these analyses, peaks corresponding to oligosaccharides containing 34 S-O-sulfo groups were integrated and peak areas of dp4, 26, 28, 210 were compared to peaks corresponding to oligosaccharides without O-sulfo groups. The ratio of peak areas indicated that the enzymatic 6-O-sulfonation of N-sulfotestosteronan was 14.13 6 0.32% efficient.
Structural Analyses of 6-O-Sulfo-Nsulfotestosteronan Using NMR Spectroscopy 
. 9 Based on these spectral data, the treatment of Nsulfotestosteronan with 6OST-1 and 6OST-3 and 34 S-labeled PAPS confirmed the formation of 6-O-sulfo, N-sulfotestosteronan in a moderate yield.
SPR Competition Assay with Heparin-Binding Proteins
The SPR competition assay was applied to determine the binding of 6-O-sulfo, N-sulfo testosteronan to various heparinbinding proteins (acidic fibroblast growth factor (FGF1), basic fibroblast growth factor (FGF2), and antithrombin (AT)). Binding to these proteins requires sulfo group substitutions so unsulfated GAGs (e.g., testosteronan, heparosan, hyaluronan) do not bind and serve as negative controls. Different sulfated GAGs were used as positive controls. SPR competition sensorgrams and bar graphs of 6-O-sulfo-N-sulfotestosteronan GAG competition levels are displayed in Figure 7 . The 6-O-sulfo-Nsulfotestosteronan showed good binding ability to FGF1; its FIGURE 2 Analysis of testosteronan by PAGE. A 6% PAGE gel was subjected to electrophoresis at 250 V for 15 min and stained with 0.05% Alcian Blue. Lanes: S, HA LoLadder; 1, 38 kDa testosteronan (3 mg); 2, 78 kDa testosteronan (3 mg). The positions of the 110 and 27 kDa bands of the ladder, and a 12 kDa HA standard (not shown on this portion of the gel) are marked with arrows (top to bottom, respectively).
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binding affinity was comparable to chondroitin sulfate E (CSE). In comparison with N-sulfotestosteronan, the data also showed that 6-O-sulfonation greatly improved the FGF1 binding affinity ( Figures 7A and 7B ). 6-O-Sulfo-N-sulfotestosteronan showed weak binding ability to FGF2 and ATIII and 6-O-sulfonation slightly improved the FGF2 and AT III binding affinity ( Figures 7C-7F ).
DISCUSSION
GAGs regulate a wide variety of biological processes and, thus, are attractive therapeutic targets. Heparin, for example, is a widely used clinical anticoagulant. 12 Previously, we identified a GAG synthase from C. testosteroni, which produced a novel GAG, testosteronan. Its backbone structure was determined as [-4-D-GlcA-a1,4-D-GlcNAc-a1-] n , similar to heparosan but with an a-configuration in the GlcA residue. Due to the different stereochemistry of the GlcA glycosidic linkage, testosteronan is not susceptible to GAG-digesting enzymes. We also speculate that it would not be lysosomally degraded if administered to an animal. The similarity to heparosan led us to investigate whether we could synthesize a novel GAG with interesting biological activities that might potentially have long in vivo half-lives because their unusual glycosidic linkage should either prevent or slow their catabolic breakdown. It is necessary to point out that semi-synthetic GAGs, such as over sulfated chondroitin sulfate (OSCS) have shown unexpected toxicity 13 and substantial in vivo studies in animals would be necessary before sulfonated testosteronan derivatives could be considered for human use.
The results of the current study demonstrate the efficient chemical conversion of testosteronan to N-sulfotestosteronan. Furthermore, our study demonstrates that N-sulfotestosteronan could not be significantly modified by native sequence 2OST or 3OST-1 under typical reaction conditions. However, 6OST-1 and 6OST-3 converted up to $20% of N-sulfotestosteronan substrate into an 6-O-sulfo-N-sulfotestosteronan.
This conversion was confirmed using a new oxidative degradation method 11 allowing the preparation of oligosaccharides from a polysaccharide not susceptible to GAG digesting enzymes. By carefully controlling the reaction conditions depolymerization can be controlled to proceed to desired levels, enabling even the analysis of oligosaccharides as large as dp20. NMR analysis showed that the O-sulfo group modification was at the C6-position of the glucosamine residue as expected.
Mass spectral analysis suggests that the 6-O-sulfo groups are uniformly distributed throughout the oligosaccharide products examined (ranging from dp4 through dp16), which were The number above each peak shows its degree of polymerization. Every odd number component shows two peaks, the one eluting first has one additional GlcNS residue, and the eluting second one labeled with an asterisk (*) has one additional GlcA residue. C: As an example, dp4 and dp8 FTMS data were shown to confirm the 34 S-labeled-sulfate has been added onto the N-sulfotestosteronan by FT-MS elemental component analysis within 3-ppm mass accuracy.
formed using oxidative cleavage. We conclude that the positioning of these 6-O-sulfo groups by 6OST-1 and 6OST-3 are most likely random based on the assumption that radicalbased oxidation is a random process. Finally, SPR analysis confirmed that the 6-O-sulfo-N-sulfotestosteronan showed enhanced binding to FGF-1 and FGF-2.
MATERIALS AND METHODS
In Vitro Synthesis of Testosteronan
The polysaccharide was produced by extension of 1.9 mM p-nitrophenyl glucuronide primer (Calbiochem) with 5 mM UDP-GlcNAc (Sigma) and 5 mM UDP-GlcUA (Sigma) in 50 mM Tris, pH 7.2, 1 mM MgCl 2 at room temperature using an E. coli-derived recombinant CtTS-containing lysate (3.4 mg/mL total protein final; prepared as in Ref. 7) in a 9.6 mL reaction. After overnight polymerization, the protein was heat precipitated at 100 C for 2 min and the reaction mixture was clarified by centrifugation at 20,000g for 5 min. The supernatant was extracted three times using n-butanol, followed by a single chloroform extraction (all 1:1 vol/vol). The polymer in the aqueous phase was adjusted to 0.3M NaCl and then precipitated with three volumes of ethanol at 4 C overnight. The pellet with $6 mg of polymer (determined using carbazole assay with GlcA standard) was re-suspended in 5.6 mL water and subjected to strong anion exchange chromatography on a 5 mL HiTrap Q HP column (GE Healthcare) equilibrated in 0.2M ammonium formate. After washing with 10-column volumes (CV) of the same buffer, UDP and UDP-sugars were removed by a 4 CV step of 0.5M ammonium formate. To isolate two different polymer sizes, the column was eluted with steps of 0.8 and 1.0M ammonium formate (each 4 CV); the smaller chains are eluted with lower ionic strength than the larger chains. The pooled 0.8M and 1.0M fractions were separately lyophilized three times from water to remove the volatile buffer. The two testosteronan polymers were assessed using 6% PAGE in 13 TBE 7 using hyaluronan (HA) standards (HA LoLadder and other standards kindly provided by Hyalose, LLC, Oklahoma City, OK). The average molecular weights were obtained using SEC-MALLS with the parameters used for hyaluronan, a polysaccharide with the identical monosaccharide composition to testosteronan. 14 
Synthesis of N-Sulfotestosteronan
N-Sulfotestosteronan was prepared according to a modified procedure using NMe 3 ÁSO 3 as the sulfonating agent.
15 Briefly, testosteronan (1.5 mg) was dissolved in 2M NaOH (375 lL) and stirred overnight at 60 C. The reaction mixture was cooled to 0 C and neutralized using 1M HCl (aq). To this reaction mixture, NMe 3 ÁSO 3 (4.5 mg) and In Vitro Enzymatic Synthesis of N-Sulfotestosteronan 681 Na 2 CO 3 (4.5 mg) were then added under argon atmosphere and stirred for 12 h at 45 C. Another portion of NMe 3 ÁSO 3 (4.5 mg) and Na 2 CO 3 (4.5 mg) was added to the reaction mixture and stirred for 12 h at 45 C. The reaction mixture was cooled to 0 C to quench the reaction. N-Sulfotestosteronan was purified by loading onto a 3000 molecular weight cut-off (MWCO) Amicon ultra (Millipore) spin column pre-rinsed with 0.1 M NaOH. The spin column was washed exhaustively with water and the retentate containing N-sulfotestosteronan was collected and lyophilized, affording purified N-sulfotestosteronan (2.5 mg) for analysis and for further reactions. Caution: chemically sulfonated polysaccharides are known to sometimes cause lethal side effects when administered intravenously so caution must be used before in vivo evaluation of N-sulfotestosteronan. 16 
Synthesis of 34 S-Labeled PAPS
Isotopically 34 S-labeled PAPS was synthesized enzymatically using crude enzymes prepared as previously described. 17 The method was modified from a similar previously described synthesis of 34 S-labeled PAPS substituting Na 2 34 SO 4 (from ISOFLEX USA). The reaction included 90 mM ATP, 100 mM MgCl 2 , 1M LiCl, 0.8 mg/mL pyrophosphatase, 0.8 mg/mL KAST, 0.8 mg/mL APS Kinase, and 50 mM Tris-HCl at pH 8.0. The reaction was incubated at 30 C for 6 h. The 34 S-labeled PAPS product was analyzed using PAMN-HPLC (polyamine II column, YMC America, Inc.) with a gradient as follows: 100% water for 10 min, followed with a linear gradient of 0-100% of 1M KH 2 PO 4 for 30 min, followed by 100% 1M KH 2 PO 4 for 15 min at a flow rate of 1 mL min 21 with UV 254 nm detection. Purification of PAPS was achieved on a DEAE-Sepharose fast flow column (GE Health; 1.5 cm 3 60 cm). The DEAE column was washed with water, and PAPS was eluted with a gradient of 0-500 mM NaCl at 5.0 mL min 21 for 200 min. Fractions containing PAPS as determined by PAMN-HPLC were pooled and stored at 280 C. The purity of the 34 S-labeled PAPS product was assessed by MS analysis and determined to be 90%1 with less than 10% PAP contamination ( Figure 5A ).
Screening of N-Sulfotestosteronan as an OST Substrate Using 35 S-Labeled PAPS
The susceptibilities of N-sulfotestosteronan to the sulfonation by different HS sulfotransferases were examined by reacting with the sulfotransferases in the presence of radioactively In Vitro Enzymatic Synthesis of N-SulfotestosteronanOST-3 (0.5 mg), and 60 mM PAPS in 2 mL. The reaction mixture was incubated at 37 C overnight, and the product was purified by a DEAE column (1 mL). The product was eluted from the DEAE column using 1M NaCl. The product was dialyzed against 25 mM ammonium bicarbonate using 3500 MWCO membrane.
Copper(II)-Catalyzed Depolymerization of 6-OSulfo-N-sulfotestosteronan
Oligosaccharides of 6-O-sulfo-N-sulfotestosteronan were obtained by controlled oxidative depolymerization using hydrogen peroxide and cupric acetate. The 6-O-sulfo-N-sulfotestosteronan polysaccharide (100 lg) was dissolved in 100 lL 0.1M sodium acetate-acetic acid solution containing 0.2 mM copper (II) acetate and adjusted to pH 7.0. Hydrogen peroxide (4 lL of 3% solution) was added with mixing and reacted at 45 C for 3 h. Sodium bisulfite was added to terminate the reaction by removing excess unreacted hydrogen peroxide and the reaction mixture was then lyophilized.
Mass Spectral Analysis of Free Radical Depolymerized Oligosaccharides
A Luna HILIC column (2.0 3 150 mm 2 , 200 Å , Phenomenex, Torrance, CA) was used to separate the oligosaccharide mixture. Mobile phase A was 5 mM ammonium acetate prepared with high performance liquid chromatography (HPLC) grade water. Mobile B was 5 mM ammonium acetate prepared in 98% HPLC grade acetonitrile with 2% of HPLC grade water. After injection of 8.0 lL oligosaccharide mixture (1.0 lg/lL) through an Agilent 1200 autosampler, HPLC binary pump was used to deliver the gradient from 10% A to 35% A over 40 min at a flow rate of 150 lL/min. The LC column was directly connected online to the standard electrospray ionization source of LTQ-Orbitrap XL FTMS (Thermo Fisher Scientific, San-Jose, CA). The source parameters for FT-MS detection were optimized using ArixtraV R (purchased at a pharmacy) to minimize the insource fragmentation and sulfate loss and maximize the signal/ noise in the negative-ion mode. The optimized parameters, used to prevent in-source fragmentation, included a spray voltage of 4.2 kV, a capillary voltage of 240 V, a tube lens voltage of 250 V, a capillary temperature of 275 C, a sheath flow rate of 30, and an auxiliary gas flow rate of 6. External calibration of mass spectra routinely produced a mass accuracy of better than 3 ppm. All FT mass spectra were acquired at a resolution 60,000 with 300-2000 Da mass range.
1D and 2D NMR Analyses
All samples were dissolved in 400 lL 
Protein-Binding Competition Study Using SPR
To test the protein-binding activity of 6-O-sulfo-N-sulfotestosteronan, SPR competition assays were performed with three heparin-binding proteins: FGF1, FGF2, or AT III (Cutter Biological, Berkley, CA). SPR measurements were performed on a BIAcore 3000 (GE Healthcare, Uppsala, Sweden) operated using BIAcore 3000 control and BIAevaluation software (version 4.0.1). The GAGs used in this study were porcine intestinal heparin (16 kDa) and porcine intestinal HS (11,700 kDa) (Celsus Laboratories, Cincinnati, OH); chondroitin sulfate A (CS-A) (20 kDa; porcine rib cartilage; Sigma, St. Louis, MO), dermatan sulfate (DS) (also known as chondroitin sulfate B; 30 kDa; porcine intestine; Sigma), chondroitin sulfate C (CS-C) (20 kDa; shark cartilage; Sigma), chondroitin sulfate D (CS-D) (20 kDa; whale cartilage; Seikagaku, Tokyo, Japan), chondroitin sulfate E (CS-E) (20 kDa; squid cartilage; Seikagaku), and hyaluronic acid sodium salt (100 kDa; Streptococus zooepidemicus; Sigma). Dermatan disulfate (Dis-DS) (4,6-di-O-sulfo-DS; 33 kDa), was prepared through the chemical 6-O-sulfonation of dermatan sulfate (Celsus) and is an inhibitor of thrombin and complement activation. 18 The biotinylated heparin was prepared by reaction of sulfo-Nhydroxysuccinimide long-chain biotin (Piece, Rockford, IL) with free amino groups of unsubstituted glucosamine residues in the polysaccharide chain following a published procedure. 19 The biotinylated heparin was immobilized to streptavidin (SA) chip (GE Healthcare, Uppsala, Sweden) based on the manufacturer's protocol. In brief, 20-lL solution of the heparin-biotin conjugate (0.1 mg/mL) in HBS-EP running buffer was injected over flow cell 2 (FC2) of the SA chip at a flow rate of 10 lL/min. The successful immobilization of heparin was confirmed by the observation of a $150 resonance unit (RU) increase in the sensor chip. The control flow cell (FC1) was prepared by 1 min injection with a saturated biotin solution.
To perform SPR competition assay, protein (500 nM) mixed with 1000 nM of 6-O-sulfo, N-sulfotestosteronan (or other GAGs as positive or negative controls) in HBS-EP buffer were injected over heparin chip at a flow rate of 30 lL/min, respectively. At the end of the sample injection, the same buffer was flowed over the sensor surface to facilitate dissociation. After a 2 min dissociation time, the sensor surface was regenerated by injecting with 30 mL of 2M NaCl to get fully regenerated surface. The response was monitored as a function of time (sensorgram) at 25 C. For each set of competition experiments on SPR, a control experiment (only protein without any GAGs) was performed to make sure the surface was completely regenerated and that the results obtained between runs were comparable.
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